100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond
FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC
GSK Bets Up to $750M on Chimagen Trispecific T Cell Engager
Jasmine Kamboj at COGC 2026: Let Us Build a Better Future of Oncology Together
Building a Palliative Care Network in Nepal: A New Model from Koshi Province
Augusto Villanueva: Could Tumor Age Reveal New Clues for HCC Treatment?
IMHOTEP: Perioperative Pembrolizumab in Localized dMMR/MSI Esophagogastric Cancer
Josep Catllà: Closing the Innovation Gap in Paediatric Oncology
